Reminder: Nasal-oral rinses using basic saline or povidone-iodine 10% solution (as well as hydrogen peroxide oral) or any other approved nasal-oral rinses cuts COVID (& thus other viral infection)

by Paul Alexander

severity, hospitilization, and death risk; the early treatment model via McCullough, Zekenko, Oskoui, Risch, Ladapo, Tyson, Vliett, Alexander etc. now updated to include nasal-oral hygeine very early



‘Participants 55 and older were enrolled within 24 hours of a + PCR COVID-19 test between September 24 and December 21, 2020. Among 826 screened, 79 participants were enrolled and randomly assigned to add 2.5 mL povidone-iodine 10% or 2.5 mL sodium bicarbonate to 240 mL of isotonic nasal irrigation twice daily for 14 days. The primary outcome was hospitalization or death from COVID-19 within 28 days of enrollment by daily self-report confirmed with phone calls and hospital records, compared to the CDC Surveillance Dataset covering the same time. Secondary outcomes compared symptom resolution by irrigant additive.


Seventy-nine high-risk participants were enrolled (mean [SD] age, 64 [8] years; 36 [46%] women; 71% Non-Hispanic White), with mean BMI 30.3. Analyzed by intention-to-treat, by day 28, COVID-19 symptoms resulted in one ED visit and no hospitalizations in 42 irrigating with alkalinization, one hospitalization of 37 in the povidone-iodine group, (1.27%) and no deaths. Of nearly three million CDC cases, 9.47% were known to be hospitalized, with an additional 1.5% mortality in those without hospitalization data. Age, sex, and percentage with pre-existing conditions did not significantly differ by exact binomial test from the CDC dataset, while reported race and hospitalization rate did. The total risk of hospitalization or death (11%) was 8.57 times that of enrolled nasal irrigation participants (SE = 2.74; P = .006). Sixty-two participants completed daily surveys (78%), averaging 1.8 irrigations/day. Eleven reported irrigation-related complaints and four discontinued use. Symptom resolution was more likely for those reporting twice daily irrigation (X2 = 8.728, P = .0031) regardless of additive.


SARS-CoV-2+ participants initiating nasal irrigation were over 8 times less likely to be hospitalized than the national rate.’

See McCullough’s stack on this:

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Antiviral Effect of Mouthwashes Against SARS-COV-2: A Systematic Review
By Peter A. McCullough, MD, MPH I noticed with the Omicron outbreak that many patients had a sore throat rather than nasal congestion as the first symptom of SARS-CoV-2 infection. When I typically get a cold, I usually have a sore throat for several days before the full-blown upper respiratory symptoms develop. I wondered if any of the any of the commercially available gargles had evidence in combatting COVID-19…
Read more